CN110938027B - Synthetic method of indole derivatives - Google Patents

Synthetic method of indole derivatives Download PDF

Info

Publication number
CN110938027B
CN110938027B CN201911141336.9A CN201911141336A CN110938027B CN 110938027 B CN110938027 B CN 110938027B CN 201911141336 A CN201911141336 A CN 201911141336A CN 110938027 B CN110938027 B CN 110938027B
Authority
CN
China
Prior art keywords
phenyl
indole
dimethyl sulfoxide
cdcl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911141336.9A
Other languages
Chinese (zh)
Other versions
CN110938027A (en
Inventor
杜云飞
李学敏
张蓓蓓
徐润瑶
赵康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Kainuo Zhongxing Technology Co ltd
Original Assignee
Hebei Kainuo Zhongxing Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Kainuo Zhongxing Technology Co ltd filed Critical Hebei Kainuo Zhongxing Technology Co ltd
Priority to CN201911141336.9A priority Critical patent/CN110938027B/en
Publication of CN110938027A publication Critical patent/CN110938027A/en
Application granted granted Critical
Publication of CN110938027B publication Critical patent/CN110938027B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)

Abstract

The invention discloses a synthesis method of indole derivatives, which comprises the following steps: dissolving a raw material o-ethynylaniline derivative (II) in dimethyl sulfoxide or deuterated dimethyl sulfoxide, dropwise adding thionyl chloride, and reacting to obtain an indole derivative (I);

Description

Synthetic method of indole derivatives
Technical Field
The invention relates to a synthesis method of indole derivatives.
Background
Indole derivatives are heterocyclic compounds with important value, and the skeleton of the indole derivatives is one of the scaffold structures with obvious advantages in a plurality of biological activity and functional molecules and natural products. [1] The sulfenyl and substituted indole functional groups play an important role in pharmaceutical chemistry and drug development, and researches show that the indole derivatives have remarkable physiological activities of resisting cancer, fungi, viruses, inflammation, depression, epilepsy and the like. [2-3] For example: indomethacin is a non-steroidal anti-inflammatory drug used for treating fever, diminishing inflammation, relieving pain and relieving stiffness; [4] l-737 can be used to treat HIV; [5] MK-886 is a drug (see formula III, formula IV, formula V) for the treatment of arteriosclerosis, leukemia, cancer. [6] The indole skeleton is a common heterocyclic pharmacophore and has very important significance for pharmaceutical chemistry research. [7] So far, chemical synthesis of indole derivatives has been reported, [8-9] however, o-ethynylbenzene is not found in these synthesesThe amine derivative (II) compound is used as a raw material, and forms the indole derivative (I) under the combined action of thionyl chloride and dimethyl sulfoxide.
Figure BDA0002281028280000011
See in particular the following references:
[1]T.Feng,X.H.Cai,Y.P.Liu,Y.Li,Y.Y.Wang,X.D.Luo,J.Nat.Prod.,2010,73,22.
[2]S.Cacchi,G.Fabrizi,Chem.Rev.,2005,105,2873.
[3]Z.Zhao,S.E.Wolkenberg,P.E.J.Sanderson,M.Lu,V.Munshi,G.Moyer,Bioorg.Med.Chem.Lett.,2008,18,554.
[4]C.Zhu,S.M.Ma,Org.Lett.,2013,15,2782.
[5]R.Ragno,M.Artico,G.D.Martino,G.L.Regina,A.Coluccia,A.D.Pasquali,R.Silvestri,J.Med.Chem.,2005,48,213.
[6]J.H.Hutchinson,Y.Li,J.M.Arruda,C.Baccei,G.Bain,C.Chapman,L.Correa,J.Darlington,C.D.King,C.Lee,D.Lorrain,P.Prodanovich,H.Rong,A.Santini,N.Stock,P.Prasit,J.F.Evans,J.Med.Chem.,2009,52,5803.
[7]R.Silvestri,G.De Martino,G.La Regina,M.Artico,S.Massa,L.Vargiu,M.Mura,A.G.Loi,T.Marceddu,P.La Colla,J.Med.Chem.,2003,46,2482.
[8]L.M.Tao,W.Q.Liu,Y.Zhou,A.T.Li.J.Chem.Res.,2012,36,644.
[9]Y.J.Guo,R.Y.Tang,J.H.Li,P.Zhong,X.G.Zhang,Adv.Synth.Catal.,2009,351,2615.
disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a synthesis method of indole derivatives for simply realizing intramolecular cyclization and methionine tandem cyclization.
The technical scheme of the invention is summarized as follows:
a synthetic method of indole derivatives comprises the following steps: dissolving a raw material o-ethynylaniline derivative (II) in dimethyl sulfoxide or deuterated dimethyl sulfoxide, dropwise adding thionyl chloride, and reacting to obtain an indole derivative (I);
Figure BDA0002281028280000021
wherein:
R 1 is a hydrogen atom, a methyl group, a fluorine atom or a bromine atom;
R 2 is phenyl, 2-bromophenyl, 3-fluorophenyl, 4-bromophenyl, 4-chlorophenyl, 4-methylphenyl, 4-methoxyphenyl, 1-naphthyl, 2-thienyl, cyclopropyl or 2- (p-toluenesulfonylamino) phenyl;
R 3 are p-toluenesulfonyl and methanesulfonyl;
R 4 is methyl or deuterated methyl.
The molar ratio of the o-ethynylaniline derivative (II) to thionyl chloride is preferably 3.
The method has the advantages of simple operation, cheap and easily obtained raw materials, mild reaction conditions, short reaction time, ideal yield and the like.
Detailed Description
Thionyl chloride (SOCl) 2 ) Analytically pure thionyl chloride purchased commercially.
Dimethyl sulfoxide (DMSO) is a commercially available absolute anhydrous dimethyl sulfoxide.
Deuterated dimethyl sulfoxide (DMSO-d) 6 ) Commercially available deuterated dimethyl sulfoxide of 99.9% purity.
The reaction starting material required in the examples, o-ethynylaniline (II), was prepared by the literature method. ([ 1 ]) Y.yin, W.Y.Ma, Z.Chai, G.ZHao, J.org.Chem.2007,72, 5731.)
The present invention will be further illustrated by the following specific examples.
Example 1
Preparation of 3-methylthio-2-phenyl-1-p-toluenesulfonyl-1H-indole-a
Figure BDA0002281028280000031
4-methyl-N- (2- (phenylethynyl) phenyl) benzenesulfonamide ll-a (0.5 mmol, 174mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 173mg of a white solid, 88% yield, melting point 104-105 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.36(d,J=8.3Hz,1H),7.68(d,J=7.4Hz,1H),7.50-7.40(m,4H),7.37(d,J=7.0Hz,3H),7.29(d,J=8.4Hz,2H),7.07(d,J=8.2Hz,2H),2.31(s,3H),2.06(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.9,142.8,137.1,135.2,131.8,131.2,130.7,129.5,129.1,127.3,126.9,125.6,124.4,119.9,117.5,116.2,21.6,18.4.HRMS(ESI)calcd for C 22 H 19 NNaO 2 S 2 + [M+Na + ]416.0749, found 416.0750 is l-a.
Example 2
Preparation of 3-methylthio-2-phenyl-1-methanesulfonyl-1H-indole l-b
Figure BDA0002281028280000032
N- (2- (phenylethynyl) phenyl) methanesulfonamide ll-b (0.5 mmol, 136mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction solution was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, the organic phase was washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to column chromatography silica gel to dryness, and the organic phase was separated by column chromatography (ethyl acetate: petroleum ether = 10) to give 139mg of a white solid with a yield of 88% and a melting point of 136-137 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.20–8.08(m,1H),7.86–7.74(m,1H),7.52–7.46(m,5H),7.46–7.39(m,2H),2.82(s,3H),2.16(s,3H). 13 C NMR(151MHz,CDCl 3 )δ142.5,136.7,131.3,131.0,130.5,129.3,127.7,125.8,124.6,120.2,117.3,115.5,40.7,18.4.HRMS(ESI)calcd for C 16 H 15 NNaO 2 S 2 + [M+Na + ]341.0436, found 340.0436, is l-b.
Example 3
Preparation of 2- (2-bromophenyl) -5, 7-dimethyl-3- (methylthio) -1-p-toluenesulfonyl-1H-indole l-c
Figure BDA0002281028280000041
N- (2- ((2-bromophenyl) ethynyl) -4, 6-dimethylphenyl) -4-methylbenzenesulfonamide ll-c (0.5mmol, 227mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5mmol, 179mg) was added dropwise at 0 ℃ and the reaction was carried out at 70 ℃ until TLC indicated complete reaction of the substrate. The reaction solution was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, the organic phase was washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column chromatography silica gel to dryness, and the organic phase was separated by column chromatography (ethyl acetate: petroleum ether = 5) to give 225mg of a white solid with a yield of 90% and a melting point of 118-119 ℃. 1 H NMR(600MHz,CDCl 3 )δ7.65-7.62(m,1H),7.37-7.34(m,1H),7.31(s,1H),7.29(dd,J=7.8,1.7Hz,1H),7.23-7.20(m,3H),7.08-7.04(m,3H),2.73(s,3H),2.43(s,3H),2.32(s,3H),2.05(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.4,143.7,136.6,135.5,134.8,133.7,133.4,133.3,132.7,131.3,130.2,129.2,128.4,126.8,126.2,125.6,121.2,118.1,22.2,21.6,21.2,17.9.HRMS(ESI)calcd for C 24 H 22 79 BrNNaO 2 S 2 + [M+Na + ]522.0168, found 522.0169 is l-c.
Example 4
Preparation of 2- (2-bromophenyl) -5-methyl-3- (methylthio) -1-toluenesulfonyl-1H-indole l-d
Figure BDA0002281028280000042
N- (2- ((2-bromophenyl) ethynyl) -4-methylphenyl) -4-methylbenzenesulfonamide ll-d (0.5 mmol, 220mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 ℃ and the reaction was carried out at 70 ℃ until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 10) to give 199mg of a white solid with a yield of 82% and a melting point of 141-144 ℃. 1 H NMR(600MHz,CDCl3)δ8.19(d,J=8.5Hz,1H),7.68(dd,J=7.9,1.1Hz,1H),7.51(s,1H),7.47(d,J=8.4Hz,2H),7.43–7.32(m,2H),7.25(m,2H),7.14(d,J=8.1Hz,2H),2.49(s,3H),2.33(s,3H),2.15(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.9,140.5,135.8,134.6,133.7,133.5,132.7,132.5,130.7,130.6,129.6,127.2,127.1,126.4,126.2,119.8,116.9,115.0,21.6,21.4,18.0.HRMS(ESI)calcd for C 23 H 20 BrNNaO 2 S 2 + [M+Na + ]509.0011, found509.0011, l-d.
Example 5
Preparation of 6-methyl-3- (methylthio) -2- (p-tolyl) -1-toluenesulfonyl-1H-indole-e
Figure BDA0002281028280000051
4-methyl-N- (5-methyl-2- (p-tolylethynyl) phenyl) benzenesulfonamide ll-e (0.5 mmol, 188mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was continued at 70 deg.C until TLC indicated complete reaction of the substrate. Extracting the reaction solution with water (20 mL) and dichloromethane (20 mL. Times.3), combining the organic phases, washing the organic phase with saturated sodium bicarbonate, washing the organic phase with saturated brine, adding anhydrous sodium sulfate, drying, adding the organic phase into column silica gel, evaporating to dryness,column chromatography (ethyl acetate: petroleum ether =5 = 95) gave 162mg of a white solid in 77% yield, melting point 163-164 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.16(s,1H),7.53(d,J=7.9Hz,1H),7.28(d,J=8.3Hz,2H),7.26(s,1H),7.18(d,J=7.9Hz,1H),7.07(d,J=8.2Hz,2H),2.55(s,3H),2.45(s,3H),2.31(s,3H),2.06(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.7,142.2,138.9,137.4,135.6,135.3,131.6,129.4,129.0,128.0,127.9,126.9,125.8,119.4,117.2,116.4,22.1,21.6,21.6,18.3.HRMS(ESI)calcd for C 24 H 23 NNaO 2 S 2 + [M+Na + ]444.1062, found 444.1064, l-e.
With N- (2- (((4-chlorophenyl) ethynyl) -5-methylphenyl) -4-methylbenzenesulfonamide
This example was repeated except that, in place of 4-methyl-N- (5-methyl-2- (p-tolylethynyl) phenyl) benzenesulfonamide, prepared were:
2- (4-chlorophenyl) -6-methyl-3- (methylthio) -1-tolyl-1H-indole
Example 6
Preparation of 2- (4-methoxyphenyl) -3- (methylthio) -1-p-toluenesulfonyl-1H-indole-e
Figure BDA0002281028280000061
N- (2- ((4-methoxyphenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide ll-f (0.5mmol, 189mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to yield 181mg of a white solid, 86% yield, mp 147-148 ℃. 1 HNMR(600MHz,CDCl 3 )δ8.35(d,J=8.3Hz,1H),7.66(d,J=7.4Hz,1H),7.45-7.38(m,1H),7.38-7.32(m,1H),7.28(dd,J=11.2,8.5Hz,4H),7.06(d,J=8.1Hz,2H),6.97(d,J=8.7Hz,2H),3.90(s,3H),2.30(s,3H),2.06(s,3H). 13 C NMR(151MHz,CDCl 3 )δ160.2,144.8,142.8,137.0,135.3,133.1,131.3,129.4,126.9,125.3,124.3,122.7,119.8,117.0,116.3,112.8,55.3,21.6,18.3.HRMS(ESI)calcd for C 23 H 21 NNaO 3 S 2 + [M+Na + ]446.0855, found446.0856, is l-f.
Example 7
Preparation of 2- (4-bromophenyl) -3- (methylthio) -1-toluenesulfonyl-1H-indole-g
Figure BDA0002281028280000062
N- (2- ((4-bromophenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide ll-g (0.5 mmol, 213mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction solution was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 155mg of a white solid, yield 66%, melting point 146-147 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.35(d,J=8.4Hz,1H),7.67(d,J=7.7Hz,1H),7.57(d,J=8.2Hz,2H),7.42(t,J=7.8Hz,1H),7.36(t,J=7.5Hz,1H),7.26(m,4H),7.07(d,J=8.1Hz,2H),2.30(s,3H),2.06(s,3H). 13 C NMR(151MHz,CDCl 3 )δ148.6,145.1,141.4,137.2,135.0,133.3,131.1,130.6,129.6,129.5,126.8,125.8,124.5,123.6,120.0,118.1,116.3,21.6,18.3.HRMS(ESI)calcd for C 22 H 18 BrNNaO 2 S 2 + [M+Na + ]494.9855, found494.9855, l-g.
With N- (2- ((3-fluorophenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide
In place of the N- (2- ((4-bromophenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide of this example, the following was prepared:
2- (3-fluorophenyl) -3- (methylthio) -1-tosyl-1H-indole
Example 8
Preparation of 5-fluoro-3- (methylthio) -2-phenyl-1-tosyl-1H-indole-H
Figure BDA0002281028280000071
N- (4-fluoro-2- (phenylethynyl) phenyl) -4-methylbenzenesulfonamide ll-h (0.5 mmol, 183mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 ℃, and the reaction was carried out at 70 ℃ until TLC showed complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 176mg of a white solid with 81% yield and melting point 120-121 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.30(dd,J=9.1,4.4Hz,1H),7.47-7.50(m,1H),7.46-7.41(m,2H),7.36(dd,J=5.1,3.3Hz,2H),7.32(dd,J=8.4,2.6Hz,1H),7.26(d,J=8.4Hz,2H),7.11-7.15(m,1H),7.07(d,J=8.1Hz,2H),2.31(s,3H),2.04(s,3H). 13 C NMR(151MHz,CDCl 3 )δ161.2,159.6,145.0,144.6,135.0,133.2,132.8,132.7,131.7,130.3,129.4,129.3,127.3,126.9,117.5,117.2,113.3,105.5,21.5,18.2.HRMS(ESI)calcd for C 22 H 18 FNNaO 2 S 2 + [M+Na + ]434.0655, found434.0656, l-h
Example 9
Preparation of 6-bromo-3- (methylthio) -2-phenyl-1-tosyl-1H-indole-i
Figure BDA0002281028280000081
N- (5-bromo-2- (phenylethynyl) phenyl) -4-methylbenzenesulfonamide ll-i (0.5mmol, 213mg) was dissolved inTo dimethylsulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise, and thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 ℃ to react at 70 ℃ until TLC showed complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 224mg of a white solid with 95% yield and 138-139 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.55(d,J=1.5Hz,1H),7.54(d,J=8.3Hz,1H),7.48(m,2H),7.43(t,J=7.5Hz,2H),7.35–7.30(m,2H),7.27(d,J=8.4Hz,2H),7.09(d,J=8.1Hz,2H),2.33(s,3H),2.02(s,3H). 13 C NMR(151MHz,CDCl 3 )δ145.2,143.2,137.6,135.1,131.8,130.1,130.0,129.5,129.3,127.6,127.3,127.0,121.0,119.1,119.0,117.0,21.6,18.3.HRMS(ESI)calcd for C 22 H 18 BrNNaO 2 S 2 + [M+Na + ]493.9855, found494.9855, is l-i
Example 10
Preparation of 2-cyclopropyl-3- (methylthio) -1-tosyl-1H-indole-l-f
Figure BDA0002281028280000082
N- (2- (cyclopropylethynyl) phenyl) -4-methylbenzenesulfonamide ll-j (0.5 mmol, 156mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed first with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 162mg of a white solid with a yield of 91% and a melting point of 66-68 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.21(d,J=8.3Hz,1H),7.65(d,J=8.4Hz,2H),7.63-7.57(m,1H),7.36-7.30(m,1H),7.30-7.26(m,1H),7.19(d,J=8.1Hz,2H),2.35(s,3H),2.28(s,3H),2.19(tt,J=8.2,5.9Hz,1H),1.22-1.00(m,4H). 13 C NMR(151MHz,CDCl 3 )δ144.7,143.1,136.6,131.1,129.7,126.5,125.0,123.7,119.3,115.6,115.0,21.5,19.2,9.3,9.0.HRMS(ESI)calcd for C 19 H 19 NNaO 2 S 2 + [M+Na + ]380.0749, found 380.0748, is l-j
Example 11
Preparation of 3- (methylthio) -2- (thiophen-2-yl) -1-tosyl-1H-indole-k
Figure BDA0002281028280000091
4-methyl-N- (2- (thien-2-ylethynyl) phenyl) benzenesulfonamide ll-k (0.5mmol, 177mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5mmol, 179mg) was added dropwise at 0 ℃ and the reaction was carried out at 70 ℃ until TLC showed complete reaction of the substrate. The reaction solution was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, the organic phase was washed with saturated sodium bicarbonate, then with saturated brine, dried by adding anhydrous sodium sulfate, the organic phase was evaporated to dryness on column chromatography on silica gel, and the mixture was separated by column chromatography (ethyl acetate: petroleum ether = 5. 1 H NMR(600MHz,CDCl 3 )δ8.35(d,J=8.4Hz,1H),7.71–7.66(m,1H),7.53(dd,J=5.0,1.2Hz,1H),7.42(m,1H),7.39–7.32(m,3H),7.16(m,2H),7.08(d,J=8.1Hz,2H),2.31(s,3H),2.13(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.9,137.3,135.3,135.0,132.2,130.8,130.2,129.4,128.6,126.9,126.4,125.9,124.3,120.0,119.7,116.1,21.6,18.6.HRMS(ESI)calcd for C 20 H 17 NNaO 2 S 3 + [M+Na + ]423.0314, found423.0314, and is l-k
Example 12
Preparation of 3- (methylthio) -2- (naphthalen-1-yl) -1-tosyl-1H-indol-l
Figure BDA0002281028280000101
4-methyl-N- (2- (naphthalen-1-ylethynyl) phenyl) benzenesulfonamide ll-l (0.5 mmol, 199mg) was dissolved in dimethyl sulfoxide (1 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction solution was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 10) to give 205mg of a white solid with a yield of 93% and a melting point of 142-143 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.45(d,J=8.4Hz,1H),7.98(d,J=8.2Hz,1H),7.88(t,J=12.4Hz,1H),7.78(d,J=7.7Hz,1H),7.55(t,J=7.6Hz,1H),7.48(dd,J=8.3,7.3Hz,1H),7.42(q,J=7.6Hz,2H),7.38(d,J=7.0Hz,1H),7.24(m,4H),6.92(d,J=8.2Hz,2H),2.24(s,3H),2.00(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.7,140.2,137.0,133.5,133.0,130.6,130.4,129.9,129.3,128.4,128.2,127.1,126.2,125.9,125.7,125.5,124.4,124.0,119.8,117.7,115.6,21.5,18.4.HRMS(ESI)calcd for C 26 H 21 NNaO 2 S 2 + [M+Na + ]467.0906, found 467.0906, l-l
Example 13
Preparation of 3- (deuterated methylthio) -2-phenyl-1-tosyl-1H-indole-m
Figure BDA0002281028280000102
4-methyl-N- (2- (phenylethynyl) phenyl) benzenesulfonamide ll-a (0.5 mmol, 174mg) was dissolved in deuterated dimethyl sulfoxide (0.5 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC showed complete reaction of the substrate. Extracting the reaction solution with water (20 mL) and dichloromethane (20 mL × 3), mixing organic phases, washing the organic phase with saturated sodium bicarbonate solution, washing the organic phase with saturated saline solution, adding anhydrous sodium sulfate, drying, passing through silica gel column, and performing column chromatography (ethyl acetate: petroleum oil)Ether = 5) was isolated to yield 152mg of a white solid with a yield of 76% and a melting point of 111-112 ℃. 1 H NMR(400MHz,CDCl 3 )δ8.36(d,J=8.3Hz,1H),7.76-7.64(m,1H),7.57-7.41(m,4H),7.41-7.32(m,3H),7.29(d,J=8.4Hz,2H),7.07(d,J=8.1Hz,2H),2.31(s,3H). 13 C NMR(151MHz,CDCl 3 )δ144.9,142.7,137.0,135.2,131.8,131.2,130.7,129.5,129.1,127.3,126.9,125.6,124.4,119.9,117.4,116.2,77.4,77.2,77.0,21.6.HRMS(ESI)calcd for C 22 H 16 D 3 NNaO 2 S 2 + [M+Na + ]419.0938, found 419.0936, is l-m
With N- (2- (phenylethynyl) phenyl) methanesulfonamide
In place of the 4-methyl-N- (2- (phenylethynyl) phenyl) benzenesulfonamide of this example, the following was prepared in the same manner as in this example:
3- (deuterated methylthio) -2-phenyl-1-methylsulfonyl-1H-indole.
Example 14
Preparation of 6-bromo-3- (deuterated methylthio) -2-phenyl-1-tosyl-1H-indole-n
Figure BDA0002281028280000111
N- (5-bromo-2- (phenylethynyl) phenyl) -4-methylbenzenesulfonamide ll-i (0.5 mmol, 213mg) was dissolved in deuterated dimethyl sulfoxide (0.5 mL), thionyl chloride (1.5 mmol,179 mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed first with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, the organic phase was evaporated to dryness on column chromatography over silica gel, and column chromatography (ethyl acetate: petroleum ether = 10) separated to give 201mg of a white solid with 85% yield and 136-137 ℃. 1 HNMR(600MHz,CDCl 3 )δ8.55(d,J=1.3Hz,1H),7.54(d,J=8.3Hz,1H),7.48(t,J=7.7Hz,2H),7.42(t,J=7.5Hz,2H),7.32(d,J=7.2Hz,2H),7.27(d,J=8.3Hz,2H),7.09(d,J=8.2Hz,2H),2.32(s,3H). 13 C NMR(151MHz,CDCl 3 )δ145.2,143.2,137.6,135.1,131.8,130.2,130.1,129.5,129.3,127.6,127.3,127.0,121.0,119.1,119.1,117.0,21.6.HRMS(ESI)calcd for C 22 H 15 D 3 79 BrNNaO 2 S 2 + [M+Na + ]497.0043, found497.0044 is l-n
With N- (4-fluoro-2- (phenylethynyl) phenyl) -4-methylbenzenesulfonamide
In place of N- (5-bromo-2- (phenylethynyl) phenyl) -4-methylbenzenesulfonamide of this example, the following was prepared:
5-fluoro-3- (deuterated methylthio) -2-phenyl-1-tosyl-1H-indole.
Example 15
Preparation of 2- (4-methoxyphenyl) -3- (deuterated methylthio) -1-toluenesulfonyl-1H-indole l-o
Figure BDA0002281028280000121
N- (2- ((4-methoxyphenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide ll-f (0.5 mmol, 189mg) was dissolved in deuterated dimethyl sulfoxide (0.5 mL), thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 ℃ and the reaction was carried out at 70 ℃ until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed with saturated sodium bicarbonate, then with saturated brine, dried over anhydrous sodium sulfate, added to a column, silica gel evaporated to dryness, and column chromatographed (ethyl acetate: petroleum ether = 5) to give 184mg of a white solid with 86% yield and 146-147 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.35(d,J=8.3Hz,1H),7.66(dd,J=7.7,0.5Hz,1H),7.44-7.38(m,1H),7.37-7.32(m,1H),7.28(dd,J=11.6,8.6Hz,4H),7.05(d,J=8.1Hz,2H),6.97(d,J=8.7Hz,2H),3.89(s,3H),2.30(s,3H). 13 C NMR(151MHz,CDCl 3 )δ160.2,144.7,142.7,137.0,135.3,133.1,131.3,129.3,126.9,125.3,124.2,122.7,119.7,116.9,116.3,112.7,55.3,21.4.HRMS(ESI)calcd for C 23 H 18 D 3 NNaO 3 S 2 + [M+Na + ]449.1043, found 449.1044 to l-o
With N- (2- (cyclopropylethynyl) phenyl) -4-methylbenzenesulfonamide
In place of the N- (2- ((4-methoxyphenyl) ethynyl) phenyl) -4-methylbenzenesulfonamide of this example, the following was prepared:
2-cyclopropyl-3- (deuterated methylthio) -1-tosyl-1H-indole.
Example 16
Preparation of 4-methyl-N- (2- (3- (deuterated methylthio) -1-toluenesulfonyl-1H-indol-2-yl) phenyl) benzenesulfonamide l-p
Figure BDA0002281028280000122
N, N' - (ethyne-1, 2-diylbis (2, 1-phenylene)) bis (4-methylbenzenesulfonamide) ll-p (0.5 mmol, 258mg) was dissolved in deuterated dimethyl sulfoxide (0.5 mL), and thionyl chloride (1.5 mmol, 179mg) was added dropwise at 0 deg.C, and the reaction was carried out at 70 deg.C until TLC indicated complete reaction of the substrate. The reaction mixture was extracted with water (20 mL) and dichloromethane (20 mL × 3), the organic phases were combined, washed first with saturated sodium bicarbonate and then with saturated brine, dried over anhydrous sodium sulfate, the organic phase was evaporated to dryness on column chromatography on silica gel, and separated by column chromatography (ethyl acetate: petroleum ether = 10) to give 257mg of a white solid with a yield of 91% and a melting point of 161-163 ℃. 1 H NMR(600MHz,CDCl 3 )δ8.39(d,J=8.4Hz,1H),7.71-7.68(m,2H),7.67-7.64(m,1H),7.49(td,J=7.3,3.7Hz,2H),7.38-7.42(m,2H),7.31-7.27(m,2H),7.17-7.07(m,5H),6.95(dd,J=7.6,1.5Hz,1H),6.75(s,1H),2.34(d,J=9.2Hz,6H). 13 C NMR(151MHz,CDCl 3 )δ145.6,143.7,137.3,137.1,136.8,136.8,134.7,132.9,130.9,130.6,129.7,129.6,127.2,127.0,126.2,124.5,123.2,122.0,120.1,119.8,119.6,116.1,21.6,21.5.HRMS(ESI)calcd for C 29 H 23 D 3 N 2 NaO 4 S 3 + [M+Na + ]588.1135, found 588.1136, is l-p
With N- (2- ((2-bromophenyl) ethynyl) -4, 6-dimethylphenyl) -4-methylbenzenesulfonamide
In place of the N, N' - (ethyne-1, 2-diylbis (2, 1-phenylene)) bis (4-methylbenzenesulfonamide) of this example, otherwise as in this example, there was prepared:
2- (2-bromophenyl) -5,7 dimethyl-3- (deuterated methylthio) -1-p-toluenesulfonyl-1H-indole.
The above description is only a part of the embodiments of the present invention, and is not intended to limit the present invention in any way, and all simple modifications, equivalent changes and modifications made to the above embodiments according to the technical spirit of the present invention are within the technical scope of the present invention.

Claims (1)

1. A synthetic method of indole derivatives is characterized by comprising the following steps: dissolving a raw material o-ethynylaniline derivative (II) in dimethyl sulfoxide or deuterated dimethyl sulfoxide, dropwise adding thionyl chloride, and reacting to obtain an indole derivative (I);
Figure FDA0002281028270000011
wherein:
R 1 is a hydrogen atom, a methyl group, a fluorine atom or a bromine atom;
R 2 is phenyl, 2-bromophenyl, 3-fluorophenyl, 4-bromophenyl, 4-chlorophenyl, 4-methylphenyl, 4-methoxyphenyl, 1-naphthyl, 2-thienyl, cyclopropyl or 2- (p-toluenesulfonylamino) phenyl;
R 3 are p-toluenesulfonyl and methanesulfonyl;
R 4 is methyl or deuterated methyl.
CN201911141336.9A 2019-11-20 2019-11-20 Synthetic method of indole derivatives Active CN110938027B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911141336.9A CN110938027B (en) 2019-11-20 2019-11-20 Synthetic method of indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911141336.9A CN110938027B (en) 2019-11-20 2019-11-20 Synthetic method of indole derivatives

Publications (2)

Publication Number Publication Date
CN110938027A CN110938027A (en) 2020-03-31
CN110938027B true CN110938027B (en) 2022-11-25

Family

ID=69907797

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911141336.9A Active CN110938027B (en) 2019-11-20 2019-11-20 Synthetic method of indole derivatives

Country Status (1)

Country Link
CN (1) CN110938027B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112358432B (en) * 2020-11-02 2022-06-10 天津大学 Synthetic method of indole derivatives
CN115093360B (en) * 2022-07-06 2023-11-17 都创(上海)医药科技股份有限公司 Synthesis method of indole derivatives

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057733A1 (en) * 2007-10-31 2009-05-07 Santen Pharmaceutical Co., Ltd. Novel indole derivative having anti-angiogenic activity
CN105693589A (en) * 2014-11-26 2016-06-22 中国科学院大连化学物理研究所 Synthesis method of indole derivative
CN105859725A (en) * 2016-05-11 2016-08-17 天津大学 5,10-dihydroindolo[3,2-b]indole derivative synthesis method
CN108752363A (en) * 2018-08-15 2018-11-06 天津大学 A kind of synthetic method of benzothiophene [3,2-b] indole derivatives
CN109232366A (en) * 2018-09-29 2019-01-18 华中师范大学 The preparation method and applications of 2- acyl group -3- amino indole class compound
CN109851608A (en) * 2019-01-21 2019-06-07 中国科学院兰州化学物理研究所 A kind of preparation method of indole-2-carboxylic acid ester
CN111004164A (en) * 2019-11-28 2020-04-14 浙江工业大学 Preparation method of polysubstituted 2-aryl indole derivative

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057733A1 (en) * 2007-10-31 2009-05-07 Santen Pharmaceutical Co., Ltd. Novel indole derivative having anti-angiogenic activity
CN105693589A (en) * 2014-11-26 2016-06-22 中国科学院大连化学物理研究所 Synthesis method of indole derivative
CN105859725A (en) * 2016-05-11 2016-08-17 天津大学 5,10-dihydroindolo[3,2-b]indole derivative synthesis method
CN108752363A (en) * 2018-08-15 2018-11-06 天津大学 A kind of synthetic method of benzothiophene [3,2-b] indole derivatives
CN109232366A (en) * 2018-09-29 2019-01-18 华中师范大学 The preparation method and applications of 2- acyl group -3- amino indole class compound
CN109851608A (en) * 2019-01-21 2019-06-07 中国科学院兰州化学物理研究所 A kind of preparation method of indole-2-carboxylic acid ester
CN111004164A (en) * 2019-11-28 2020-04-14 浙江工业大学 Preparation method of polysubstituted 2-aryl indole derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"2-叔丁基-3-苯硫基-1H-吲哚的合成研究";李爱桃等;《化学世界》;20130925;第54卷(第9期);第551-553页 *
"Microwave assisted metal-/oxidant-free cascade electrophilic sulfenylation/5-endo-dig cyclization of 2-alkynylanilines to generate diversified 3-sulfenylindoles";Sharma, Shivani等;《Tetrahedron Letters》;20171231;第58卷(第40期);第3823-3826页 *

Also Published As

Publication number Publication date
CN110938027A (en) 2020-03-31

Similar Documents

Publication Publication Date Title
CN110938027B (en) Synthetic method of indole derivatives
CN1543455B (en) 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
CN111825585B (en) Aryl sulfide containing benzylamine structure and synthesis method and application thereof
JPS5939428B2 (en) Method for producing a 5(6)-benzene ring-substituted benzimidazole-2-carbamate derivative having anthelmintic effect
CA2457676A1 (en) Chemotherapeutic agents
Wróbel Silane-mediated direct condensation of nitroarenes with cinnamyl-type sulfones. The way to 2-aryl-4-X-quinolines and their hetero analogs
CN112321481B (en) Chiral indole compound and preparation method thereof
Liu et al. Non-directed copper-catalyzed regioselective C–H sulfonylation of phenothiazines
Knight et al. 5-endo-dig Cyclisations of homopropargylic sulfonamides: a new route to 2, 3-dihydropyrroles and β-iodopyrroles
Hu et al. Copper‐Catalyzed Hydrosulfonylation of Alkynes Employing Sulfonohydrazides toward the Synthesis of Vinyl Sulfones
CN112358432B (en) Synthetic method of indole derivatives
US20200030303A1 (en) Compositions and methods for inhibiting protein kinases
JP2014505043A (en) Process for producing N-sulfonyl-substituted oxindoles
CN109320503A (en) Benzimidazole alkynes aminated compounds without metal one-pot synthesis method
CN112341368B (en) Method for synthesizing alpha-fluorinated thioacrylamide derivative
CN115093360B (en) Synthesis method of indole derivatives
Adam et al. Sulfoxides of penicillanates with non classical substituents in the 6-position
Ren et al. Synthesis and potent biological activity of 1-sulfonyl substituted imidazole and benzo [d] imidazole compounds
JP2022545773A (en) Process for preparing carboxylic acid derivatives of 3-bromo-4,5-dihydro-1H-pyrazole
CN109485611A (en) A kind of preparation method of triazole derivatives
CN112159364B (en) Synthetic method of isothiazole derivative
CN108003103B (en) Synthetic method of sulfonylated 5-aminopyrazole compound
KR102325534B1 (en) Synthesis of Sulfones and Sulfonyl Derivatives using Sodium (tert-butyldimethylsilyl)oxymethanesulfinate
CN108586406A (en) A kind of preparation method of 3- sulfuryls coumarin compound
CN116041251A (en) Synthesis method of sulfonyl tetrahydropyridine derivative containing halogen atom

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20221021

Address after: No. 156, Taxi Street, Circular Chemical Industry Park, Shijiazhuang City, Hebei Province 050,099

Applicant after: Hebei Kainuo Zhongxing Technology Co.,Ltd.

Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92

Applicant before: Tianjin University

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant